IRulya Therapeutics (IRLA) EBITDA (2018 - 2026)
IRulya Therapeutics (IRLA) reported EBITDA of -$79.74 million for Q2 2026, compared with -$10.39 million a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) EBITDA (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, IRulya Therapeutics' EBITDA came in at -$127 million; for FY2025, it was -$57.93 million.
- By year, EBITDA came in at -$57.1 million in FY2024, -$34.3 million in FY2023, -$51.81 million in FY2022 and -$89.97 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBITDA in data going back to Q1 2018.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$14.55 million (Q1 2026), -$19.31 million (Q4 2025) and -$13.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | -79.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.74 Mn |
| Mar 31, 2026 | -14.55 Mn |
| Dec 31, 2025 | -19.31 Mn |
| Sep 30, 2025 | -13.39 Mn |
| Jun 30, 2025 | -10.39 Mn |
| Mar 31, 2025 | -14.83 Mn |
| Dec 31, 2024 | -12.00 Mn |
| Sep 30, 2024 | -5.78 Mn |
| Jun 30, 2024 | -28.15 Mn |
| Mar 31, 2024 | -11.18 Mn |
| Dec 31, 2023 | -9.62 Mn |
| Sep 30, 2023 | -6.09 Mn |
| Jun 30, 2023 | -5.58 Mn |
| Mar 31, 2023 | -12.94 Mn |
| Dec 31, 2022 | -6.28 Mn |
| Sep 30, 2022 | -7.58 Mn |
| Jun 30, 2022 | -16.17 Mn |
| Mar 31, 2022 | -21.83 Mn |
| Dec 31, 2021 | -23.46 Mn |
| Sep 30, 2021 | -21.59 Mn |
API Access
IRulya Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();